Search “Zepbound coupon” and you get one answer. Read Lilly’s actual terms and you find at least three separate programs with different eligibility rules, different prices, and different fill limits, plus a large group of people who are shut out of all of them by federal law.
This page reports what Lilly’s own terms and conditions say as of September 4, 2026: the exact copay in each tier, who qualifies, what the caps are, when the cards expire, and what the uninsured are steered toward instead. It does not restate the full dose-by-dose self-pay ladder; that lives on our Zepbound cost guide.
What Does the Zepbound Savings Card Cost?
The card does not have one price. It has a price per situation.
| Route | Low | Average | High |
|---|---|---|---|
| Savings card, commercial plan covers Zepbound (single-dose pen) | $25/mo | $25/mo | $25/mo |
| Savings card, commercial plan excludes Zepbound (KwikPen) | $299/mo | $449/mo | $449/mo |
| Savings card, commercial plan excludes Zepbound (single-dose pen) | $499/mo | $499/mo | $499/mo |
| KwikPen Self-Pay Savings Card (uninsured or cash-paying) | $299/mo | $449/mo | $449/mo |
| SingleCare discount card, 2.5 mg KwikPen | $490/mo | $509/mo | $529/mo |
| No card at all, retail counter | $655/mo | $1,052/mo | $1,086/mo |
| Medicare, Medicaid, TRICARE or VA | not eligible for any manufacturer card |
Every Lilly row above is taken from the eligibility and terms text Lilly publishes on its Zepbound savings pages. The SingleCare row is that site’s live Zepbound page, read twice on September 4, 2026. The no-card row spans SingleCare’s average retail price for the 2.5 mg KwikPen up to the roughly $1,086 monthly list price of the single-dose pen.
Tier 1: commercial insurance that covers Zepbound
This is the headline offer. Lilly’s terms state you must have commercial drug insurance that covers the Zepbound single-dose pen, plus a prescription for an FDA-approved use, to “pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill.”
Note a wording quirk worth knowing before you argue with a pharmacist: Lilly’s summary banner on the coverage page describes it as a “one- or three-month supply,” while the terms and conditions text says one, two, or three months. The terms are the operative document.
The limits are real. Maximum savings run up to $100 per one-month fill, $200 per two-month fill, and $300 per three-month fill, with a separate maximum annual savings of $1,300 per calendar year and up to 13 prescription fills per calendar year. If your plan’s coinsurance on a roughly $1,086 list-price drug exceeds $1,300 a year, the card runs out before your year does.
Tier 2: commercial insurance that excludes Zepbound
Plenty of commercial plans still carve out weight-management drugs. That does not disqualify you, it just moves you to a different price.
For the single-dose pen, Lilly’s terms say you pay “as low as $499 for your 1-month prescription fill,” with maximum monthly savings calculated as wholesale acquisition cost minus $499, and the same 13-fills-per-year limit.
For the KwikPen, the ladder is better and it matches Lilly’s self-pay pricing: as low as $299 at 2.5 mg (maximum monthly savings up to $215), $399 at 5 mg (up to $115), $449 at 7.5 mg (up to $65), and $449 at 10 mg, 12.5 mg, and 15 mg (up to $271). Lilly notes the 7.5 mg and higher savings are also subject to purchase offer terms, which is where the 45-day refill requirement lives.
Tier 3: uninsured and cash-paying patients
The copay card is closed to you. Both commercial tiers begin with “You must have commercial drug insurance.”
Lilly runs a separate program instead: the Zepbound KwikPen Self-Pay Savings Card. Its terms state it “is for self-paying (cash) patients and operates outside of any health insurance program.” Pricing matches the non-covered KwikPen ladder: $299 at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg through 15 mg, with the same maximum monthly savings figures.
Two differences matter. The self-pay card is capped at up to 11 prescription fills per calendar year rather than 13. And you must agree not to seek or accept reimbursement for those out-of-pocket costs from any third-party payer, which rules out submitting the receipt to a health plan later.
The other cash route is buying direct from Lilly at the self-pay price, which lands at the same $299 to $449. Our cheapest way to get Zepbound guide compares those two paths in detail.
What Drives Which Tier You Land In
Your insurance type, not your income. Lilly’s Zepbound cards are not income-tested at all. There is no application, no proof of hardship, and no sliding scale. The only questions are whether you have commercial drug coverage and whether that coverage includes Zepbound.
The format on your prescription. The $25 and $499 tiers are written against the single-dose pen. The $299 to $449 tiers are written against the single-patient-use KwikPen. Same drug, different card language, several hundred dollars of difference.
Alternate funding programs. Lilly’s terms specifically disqualify you if your plan participates in an alternate funding program that requires you to apply to the savings card as a condition of coverage. Some employer plans do exactly this, and it voids the card.
Where you live. Card savings are not valid for Massachusetts residents if an AB-rated generic equivalent is available, or for California residents if an FDA-approved therapeutic equivalent is available. Neither applies to tirzepatide today, since no generic exists, but the clause is in the terms.
Lilly’s discretion. The terms let Lilly reduce, eliminate, or modify savings at any time, including specifically if your plan imposes requirements that limit coverage, applies a copay maximizer, or does not apply card payments toward your deductible.
Why Medicare and Medicaid Are Shut Out
This is the single most common reason a Zepbound coupon gets rejected at the counter, and it is not a pharmacy error.
Lilly’s eligibility criteria state you must not be “enrolled in any state, federal, or government funded healthcare program,” and the terms list Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, and any state prescription drug assistance program by name. The terms go further: if you begin receiving drug coverage under any such program while enrolled, you stop being eligible and are asked to call the program to stop participating.
This is a federal anti-kickback constraint, not a Lilly preference, and every manufacturer copay card in the country carries the same exclusion. It applies even if your Medicare plan refuses to cover Zepbound.
CMS closes the loop from the other direction. In its guidance for the Medicare GLP-1 Bridge, the demonstration that gives eligible Part D beneficiaries certain GLP-1 drugs for $50 a month between July 1, 2026 and December 31, 2027, CMS states that coupons and discount programs may not be applied to Bridge claims at all. Medicare.gov separately notes that discount cards are not creditable coverage and do not count toward your Medicare deductible or out-of-pocket maximum.
The practical version: if you are on Medicare, your Zepbound routes are your Part D plan (which can cover it for moderate-to-severe obstructive sleep apnea with obesity), the $50 GLP-1 Bridge copay if you qualify, or paying Lilly’s cash self-pay price out of pocket. A manufacturer card is not on that list.
Third-Party Discount Cards as the Fallback
If you cannot use a Lilly card and you are not buying direct, a pharmacy discount card is the remaining lever. It is a weak one here.
SingleCare’s Zepbound page shows an average retail price of $655.33 for one 2.4 mL KwikPen at 2.5 mg/0.6 mL, with a card price as low as $490.02 for the same item. Per-pharmacy rows on that read ranged from $490.02 to $528.94. Treat named-chain prices as illustrative: those tables shift between sessions and locations, and the stable figures are the average retail price and the “as low as” number.
So the best third-party card price on the starting dose is roughly $191 above Lilly’s $299. The reason is structural. Discount cards earn their keep on generics with wide acquisition-to-retail spreads, and tirzepatide has no FDA-approved generic, which also means generic-focused pharmacies have no Zepbound product to sell. Our GoodRx vs. SingleCare guide covers where these cards genuinely win, and our tirzepatide cost guide documents the no-generic situation.
How to Pay Less
-
Find out whether your plan covers Zepbound before you assume anything. The difference between the covered and non-covered tier is $25 versus $499 on the same pen. One phone call to the number on your insurance card settles it.
-
If you are uninsured, skip the copay card entirely. Go straight to the self-pay KwikPen card or to buying direct from Lilly. Both land at $299 to $449, and you avoid an application you cannot qualify for.
-
Ask for the KwikPen rather than the single-dose pen when your plan excludes Zepbound. The card language prices the KwikPen at $299 to $449 and the single-dose pen at $499.
-
Protect the refill window. The 7.5 mg and higher card savings sit under purchase offer terms that require refilling within 45 days. Missing it moves you onto the regular price ladder.
-
Re-enroll before December 31, 2026. Every Lilly Zepbound card states that savings end on that date. Cards are typically reissued for the new year, but nothing guarantees the same prices carry over.
-
Keep the prescribing visit cheap. The card covers the drug, not the appointment. A free or sliding-scale clinic can handle the visit, and if a related bill goes sideways, negotiating medical bills is a real option.
Bottom Line
The Zepbound savings card is worth having if you have commercial drug insurance, and worth ignoring if you do not. Covered commercial plans reach $25 a month with a $1,300 annual ceiling. Non-covered commercial plans reach $299 to $499. Uninsured cash payers get a separate self-pay card at $299 to $449 with an 11-fill annual limit. Everyone on a government program is excluded outright and should be looking at Part D coverage or the $50 Medicare GLP-1 Bridge instead.
All of it expires 12/31/2026 by its own terms, and Lilly can change any of it without notice. For the full price picture including what a pharmacy pays and what Medicare costs, start with our Zepbound cost guide, or compare across brands with the Mounjaro cost guide.